Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15 - Wolf, R; Howard, O M; Dong, H F (J Immunol, 2008)
et al.